|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 12, 2016 ) Metabolic disorders occur as a result of disruption of chemical processes and conversions occurring in the cells and fluids of the body. This is mainly because of defects in the enzyme; all process in the body are controlled by enzymes. Any disruption in the pathways involved in the development and metabolism of carbohydrates, proteins, fats, and nucleic acids, results in the development of metabolic disorders.
Publisher's analysts forecast the global metabolic disorders therapeutics market to grow at a CAGR of 4.62% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-metabolic-disorders-therapeutics-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the global metabolic disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various metabolic disorders including diabetes, obesity, lysosomal storage diseases, and hypercholesterolemia.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Metabolic Disorders Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Novo Nordisk
-Sanofi
-Merck
-AstraZeneca
-Eli Lilly
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001420943/sample
Other prominent vendors
-AbbVie
-Actelion Pharmaceuticals
-Adocia
-Aegerion Pharmaceuticals
-Akros Pharma
-Alnylam Pharmaceuticals
-Amarin
-nAmgen
-Amicus Therapeutics
-Arbutus Biopharma
-Arena Pharmaceuticals
-Astellas Pharma
-Atheronova
-Aurobindo Pharma
-Baxalta
-Belrose Pharma
-BHV Pharma
-Biocon
-Biodel
-BioMarin
-Bionaturis
-Biosidus
-Biospherics
-Boehringer Ingelheim
-Bristol-Myers Squibb
-Catabasis Pharmaceuticals
-Cerenis Therapeutics
-Chipscreen Biosciences
-Cipla
-CJ HealthCare
-CKD Bio
-Concord Biotech
-ConjuChem
-CureDm
-CymaBay Therapeutics
-Daewoong
-Daiichi Sankyo
-Dance Biopharm
-DiaMedica
-Diamyd Therapeutics
-Diasome Pharmaceuticals
-DiaVacs
-Dong-A ST
-Eisai
-Elcelyx Therapeutics
-Esperion Therapeutics
-Exsulin
-F. Hoffmann-La Roche
-Gan & Lee Pharmaceuticals
-Generex Biotechnology
-Genfit
-GlaxoSmithKline
-HanAll BioPharma
-Hanmi Pharmaceutical Company
-Hua Medicine
-Iltoo Pharma
-Intarcia Therapeutics
-InteKrin Therapeutics
-Intrexon
-Ionis Pharmaceuticals
-Islet Sciences
-ISU Abxis
-Janssen Pharmaceuticals
-Japan Tobacco
-JCR Pharmaceuticals
-JW Pharmaceuticals
-Kadmon Pharmaceuticals
-Kamada
-KinDex Pharmaceuticals
-Kissei
-Kotobuki
-Kowa Company
-Laboratoires SMB
-Lexicon Pharmaceuticals
-Ligand Pharmaceuticals
-Living Cell Technologies
-Livzon
-LIXTE Biotechnology
-Lupin
-MacroGenics
-Madrigal Pharmaceuticals
-MannKind
-MedImmune
-Melior Pharmaceuticals
-Merrion Pharmaceuticals
-Merz Pharmaceuticals
-Metabolic Solutions Development Company
-Mitsubishi Tanabe Pharma
-Mylan
-Neothetics
-Neuraltus Pharmaceuticals
-NGM Biopharmaceuticals
-NGM Biopharmaceuticals
-Norgine BV
-Novartis
-NuSirt Biopharma
-Oramed
-Orexigen Therapeutics
-Osiris Therapeutics
-Peptron
-Perle Biosciences
-Pfizer
-PhaseBio Pharmaceuticals
-Poxel
-Protalix Biotherapeutics
-Raptor
-Recordati
-Regeneron Pharmaceuticals
-Regeneron Pharmaceuticals
-REGiMMUNE
-Rhythm Pharmaceuticals
-Saniona
-Santaris Pharma
-Santaris Pharma
-Serometrix
-Shionogi
-Shire
-Sigma-Tau
-Sirona Biochem
-Strongbridge Biopharma
-SUN Pharma
-Takeda
-Teva
-Thera technologies
-Theracos
-Toleranzia
-Tolerion
-Torrent Pharmaceuticals
-Transition Therapeutics
-UCB
-Utrecht Holdings
-VeroScience
-Vivus
-vTv Therapeutics
-XBiotech
-Xeris Pharmaceuticals
-XOMA
-Zafgen
-Zydus Cadila
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001420943/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
